What is Avenir Wellness Solutions, Inc. (AVRW)?

Avenir Wellness Solutions, Inc. (AVRW) is a stock in the Consumer Defensive sector, Packaged Foods industry. View full analysis on Stocks360.

What is the current price of AVRW?

The current price of AVRW is $0.00. Prices are updated in real time on Stocks360.

What is AVRW's price-to-earnings (PE) ratio?

AVRW's trailing twelve-month PE ratio is -0.00, based on current price and earnings per share data available on Stocks360.

What is AVRW's market capitalization?

AVRW's market capitalization is $16,615.00, placing it in the small-cap tier.

Avenir Wellness Solutions, Inc. (AVRW)

Stock analysis · OTC · Consumer Defensive · Packaged Foods

$0.00

Market Cap

$16.61K

PE (TTM)

-0.00

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.06

Day Range

$0.00 – $0.00

52-wk Range

$0.00 – $0.25

Avg Volume

N/A

Volume

242.45K

Avenir Wellness Solutions, Inc. (AVRW) is a publicly traded company in the Consumer Defensive sector. Latest price: $0.00. Market cap $16.61K. Trailing PE -0.00. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-27 · $0.00 2026-10-23 · $0.00 (+19900.00%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Avenir Wellness Solutions, Inc.

Avenir Wellness Solutions, Inc., operating through its subsidiary The Sera Labs, Inc., specializes in crafting advanced nutraceutical formulations and innovative delivery technologies. Their objective is to maximize product effectiveness and enhance overall well-being. The company offers a diverse range of products across the beauty, health and wellness, and pet care segments, sold under the Seratopical, Seratopical Revolution SeraLabs, and Nutri-Strips brands. Distribution channels include major drugstores, supermarkets, convenience stores, and mass retailers. Additionally, Avenir Wellness Solutions supplies products under private labels to other retailers and multi-level marketing firms, and directly to consumers online, including through subscription services. Established in 2014, the company was formerly known as CURE Pharmaceutical Holding Corp. before adopting its current name in October 2022. Its corporate headquarters are located in Sherman Oaks, California.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.00×
P/S (TTM)	0.00×
P/B	-0.00×
P/FCF (TTM)	-0.00×
EV / EBITDA	-2.58×
EV / Sales	1.90×
Earnings Yield	-23886.24%
Free Cash Flow Yield	-23454.71%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$8.25M
Revenue (TTM)	$4.35M
Net Income (TTM)	-$3.97M
Free Cash Flow (TTM)	-$3.79M
Net Debt	$8.23M
Working Capital	-$10.54M
Gross Margin	71.52%
Operating Margin	-126.66%
Net Margin	-79.23%
Return on Equity	40.54%
Return on Invested Capital	343.48%